Variable prediction accuracy of polygenic scores within an ancestry group

  1. Hakhamanesh Mostafavi  Is a corresponding author
  2. Arbel Harpak  Is a corresponding author
  3. Ipsita Agarwal
  4. Dalton Conley
  5. Jonathan K Pritchard
  6. Molly Przeworski  Is a corresponding author
  1. Columbia University, United States
  2. Princeton University, United States
  3. Stanford University, United States

Abstract

Fields as diverse as human genetics and sociology are increasingly using polygenic scores based on genome-wide association studies (GWAS) for phenotypic prediction. However, recent work has shown that polygenic scores have limited portability across groups of different genetic ancestries, restricting the contexts in which they can be used reliably and potentially creating serious inequities in future clinical applications. Using the UK Biobank data, we demonstrate that even within a single ancestry group (i.e., when there are negligible differences in linkage disequilibrium or in causal alleles frequencies), the prediction accuracy of polygenic scores can depend on characteristics such as the socio-economic status, age or sex of the individuals in which the GWAS and the prediction were conducted, as well as on the GWAS design. Our findings highlight both the complexities of interpreting polygenic scores and underappreciated obstacles to their broad use.

Data availability

The GWAS summary statistics generated in this study have been uploaded to Dryad.

The following data sets were generated

Article and author information

Author details

  1. Hakhamanesh Mostafavi

    Department of Biological Sciences, Columbia University, New York, United States
    For correspondence
    hsm2137@columbia.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1060-2844
  2. Arbel Harpak

    Department of Biological Sciences, Columbia University, New York, United States
    For correspondence
    ah3586@columbia.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3655-748X
  3. Ipsita Agarwal

    Department of Biological Sciences, Columbia University, New York, United States
    Competing interests
    No competing interests declared.
  4. Dalton Conley

    Department of Sociology, Princeton University, Princeton, United States
    Competing interests
    No competing interests declared.
  5. Jonathan K Pritchard

    Department of Genetics, Stanford University, Stanford, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8828-5236
  6. Molly Przeworski

    Department of Systems Biology, Columbia University, New York, United States
    For correspondence
    mp3284@columbia.edu
    Competing interests
    Molly Przeworski, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5369-9009

Funding

National Institute of General Medical Sciences (GM121372)

  • Molly Przeworski

National Human Genome Research Institute (HG008140)

  • Jonathan K Pritchard

Robert Wood Johnson Foundation (84337817)

  • Dalton Conley

Simons Foundation (633313)

  • Arbel Harpak

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: This study has been conducted using the UK Biobank resource under application Number 11138, as approved by Columbia University Institutional Review Board, protocol AAAS2914.

Copyright

© 2020, Mostafavi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 11,824
    views
  • 1,653
    downloads
  • 295
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hakhamanesh Mostafavi
  2. Arbel Harpak
  3. Ipsita Agarwal
  4. Dalton Conley
  5. Jonathan K Pritchard
  6. Molly Przeworski
(2020)
Variable prediction accuracy of polygenic scores within an ancestry group
eLife 9:e48376.
https://doi.org/10.7554/eLife.48376

Share this article

https://doi.org/10.7554/eLife.48376

Further reading

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Federico A Vignale, Andrea Hernandez Garcia ... Adrian G Turjanski
    Research Article

    Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.

    1. Genetics and Genomics
    Thomas J O'Brien, Ida L Barlow ... André EX Brown
    Research Article

    There are thousands of Mendelian diseases with more being discovered weekly and the majority have no approved treatments. To address this need, we require scalable approaches that are relatively inexpensive compared to traditional drug development. In the absence of a validated drug target, phenotypic screening in model organisms provides a route for identifying candidate treatments. Success requires a screenable phenotype. However, the right phenotype and assay may not be obvious for pleiotropic neuromuscular disorders. Here, we show that high-throughput imaging and quantitative phenotyping can be conducted systematically on a panel of C. elegans disease model strains. We used CRISPR genome-editing to create 25 worm models of human Mendelian diseases and phenotyped them using a single standardised assay. All but two strains were significantly different from wild-type controls in at least one feature. The observed phenotypes were diverse, but mutations of genes predicted to have related functions led to similar behavioural differences in worms. As a proof-of-concept, we performed a drug repurposing screen of an FDA-approved compound library, and identified two compounds that rescued the behavioural phenotype of a model of UNC80 deficiency. Our results show that a single assay to measure multiple phenotypes can be applied systematically to diverse Mendelian disease models. The relatively short time and low cost associated with creating and phenotyping multiple strains suggest that high-throughput worm tracking could provide a scalable approach to drug repurposing commensurate with the number of Mendelian diseases.